Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more
Patent Box Article (2)
European, News 08/04/2024

The Patent Box: A Guide to Boosting Your Innovation

B012621
Events, News 04/04/2024

Secerna to attend Diagnostics North East Conference 2024

Antibodies
European, News 14/03/2024

Update on the patentability of antibodies at the European Patent Office

Secerna Website Images 2023 (41)
Events 10/03/2024

Jason Boakes will be in Atlanta during the INTA Annual Conference period

Secerna To Attend BIO International San Diego
Events 09/03/2024

Secerna to attend BIO International Convention in San Diego, USA

Secerna Website Images 2023 (40)
News 08/03/2024

Seen and Saved: Protecting Innovation in High-Visibility Clothing Technology

JP3 1192
European, Industry news, News 06/03/2024

Important Update: EPO Guidelines for Examination 2024 Now in Effect

EPO 2021
European, Industry news, News 05/03/2024

EPO Clarifies "Method of Treatment" Objections for MedTech Innovations

European Parliament
European, News, UPC 01/03/2024

EU Parliament Votes in Favour of New SEP Regulation, Despite Intense Industry Criticism

8 9 10 11 12 13 14 15 16 17 18